Half-curcumin Analogues As PET Imaging Probes for Amyloid Beta Species
Overview
Authors
Affiliations
In this report, we demonstrate that half-curcuminoid could be a better scaffold for PET tracer development. F-CRANAD-101 was designed and found to show significant response to both soluble and insoluble Aβs in the fluorescent spectral tests. PET imaging results indicated that 14 month and 5 month old APP/PS1 AD mice had higher signals in the brain than age-matched wild type mice.
Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer's disease.
Zhou C, Zeng F, Yang H, Liang Z, Xu G, Li X Eur J Nucl Med Mol Imaging. 2024; 51(10):2953-2969.
PMID: 38502215 DOI: 10.1007/s00259-024-06690-1.
Recent Research Progress in Fluorescent Probes for Detection of Amyloid-β In Vivo.
Zhang Z, Li Z, Tang Y, Xu L, Zhang D, Qin T Biosensors (Basel). 2023; 13(11).
PMID: 37998165 PMC: 10669267. DOI: 10.3390/bios13110990.
Radiolabeled Chalcone Derivatives as Potential Radiotracers for β-Amyloid Plaques Imaging.
Capponi P, Mari M, Ferrari E, Asti M Molecules. 2023; 28(7).
PMID: 37049995 PMC: 10096019. DOI: 10.3390/molecules28073233.
Curcumin Scaffold as a Multifunctional Tool for Alzheimer's Disease Research.
Yang H, Zeng F, Luo Y, Zheng C, Ran C, Yang J Molecules. 2022; 27(12).
PMID: 35745002 PMC: 9227459. DOI: 10.3390/molecules27123879.
Improved Synthesis of Asymmetric Curcuminoids and Their Assessment as Antioxidants.
Cheng Y, Li C, Kuo C, Shih T, Chen J Molecules. 2022; 27(8).
PMID: 35458741 PMC: 9030899. DOI: 10.3390/molecules27082547.